Correlation Between Viridian Therapeutics and Iteos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Iteos Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Iteos Therapeutics.

Diversification Opportunities for Viridian Therapeutics and Iteos Therapeutics

0.69

Correlation Coefficient

Viridian Therapeutics  Iteos Therapeutics

Poor diversification

The 3 months correlation between Viridian and Iteos is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Iteos Therapeutics

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.13 times more return on investment than Iteos Therapeutics. However, Viridian Therapeutics is 1.13 times more volatile than Iteos Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Iteos Therapeutics is currently generating about 0.17 per unit of risk. If you would invest  1,294  in Viridian Therapeutics on May 16, 2025 and sell it today you would earn a total of  550.00  from holding Viridian Therapeutics or generate 42.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Iteos Therapeutics

Viridian Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Iteos Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Iteos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Iteos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Viridian Therapeutics and Iteos Therapeutics

The main advantage of trading using opposite Viridian Therapeutics and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.

The idea behind Viridian Therapeutics and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.